Brief: Pliant Therapeutics Q2 Net Income USD -22.371 Million
11/08/2026 21:06
BRIEF-Pliant Therapeutics Q2 Net Income USD -22.371 Million Aug 11 (Reuters) - Pliant Therapeutics Q2 operating expenses USD -23.862 million.
- Q2 operating income USD -23.862 million
Recent news on Pliant Therapeutics
See all newsBrief: Pliant Therapeutics Announces Presentations At The 2026 Annual Meeting
Brief: Pliant Therapeutics Appoints David Raben, M.D., As Chief Medical Officer
RCS - Redx Pharma Limited - Redx Announces Final Audited Results
RCS - Redx Pharma Limited - Close of Series A; Strengthened Board Composition
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals